Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

Hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic ...

Tamil Nadu enhances vaccination coverage with weekly sessions at health centers, ensuring immunization for all.

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...

The largest declines in total vaccination rates in Kindergarteners occurred in Concordia and Jefferson Davis parishes. Here ...

supported by an expanding U.S. hepatitis B vaccine market and expected market share gains. The company plans to advance its Z1018 shingles vaccine program, aiming to establish proof of concept ...